Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing

Journal of Clinical Microbiology

Volumn 45, Issue 2, 2007, Pages 517-521

  McNulty, Amanda ^a   Jennings, Cheryl ^b   Bennett, Diane ^a   Fitzgibbon, Joseph ^c   Bremer, James W ^b   Ussery, Michael ^c   Kalish, Marcia L ^a   Heneine, Walid ^a   Garcia Lerma, J Gerardo ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD ANALYSIS; DRIED BLOOD SPOT; GENE AMPLIFICATION; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRUCTURAL GENE; VIRUS LOAD;

BLOOD SPECIMEN COLLECTION; DNA, VIRAL; DRUG RESISTANCE, VIRAL; HIV INFECTIONS; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; RNA, VIRAL; SEQUENCE ANALYSIS, DNA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33847071584     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02016-06     Document Type: Article

References (25)

1. Adjé, C., R. Cheingsong, T. H. Roels, C. Maurice, G. Djomand, W. Verbiest, K. Hertogs, B. Larder, B. Monga, M. Peelers, S. Eholie, E. Bissagene, M. Coulibaly, R. Respess, S. Z. Wiktor, T. Chorba, J. N. Nkengasong, and the UNAIDS HIV Drug Access Initiative, Cote d'Ivoire. 2001. High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Cote d'Ivoire. J. Acquir. Immune Defic. Syndr. 26:501-506.
2. Beck, I. A., K. D. Drennan, A. J. Melvin, K. M. Mohan, A. M. Herz, J. Alarcon, J. Piscoya, C. Velazquez, and L. M. Frenkel. 2001. Simple, sensitive, and specific detection of human immunodeficiency virus type 1 subtype B DNA in dried blood samples for diagnosis in infants in the field. J. Clin. Microbiol. 39:29-33.
3. Bennett, D. E., M. A. Winters, W. Heneine, L. McCormick, J. Johnson, J. G. Garcia-Lerma, I. Zaidi, and H. Weinstock. 2005. Concordance of HIV drug resistance genotyping results from paired PBMC and plasma specimens from persons newly diagnosed with HIV. Antivir. Ther. 10:S176.
4. Bi, X., H. Gatanaga, S. Ida, K. Tsuchiya, S. Matsuoka-Aizawa, S. Kimura, and S. Oka. 2003. Emergence of protease inhibitor resistance-associated mutations in plasma HIV-1 precedes that in proviruses of peripheral blood mononuclear cells by more than a year. J. Acquir. Immune Defic. Syndr. 34:1-6.
5. Brambilla, D., C. Jennings, G. Aldrovandi, J. Bremer, A. M. Comeau, S. A. Cassol, R. Dickover, J. B. Jackson, J. Pitt, J. L. Sullivan, A. Butcher, L. Grosso, P. Reichelderfer, and S. A. Fiscus. 2003. Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability. J. Clin. Microbiol. 41:1888-1893.
6. Bruisten, S. M., P. Reiss, A. E. Loeliger, P. van Swieten, R. Schuurman, C. A. Boucher, G. J. Weverling, and J. G. Huisman. 1998. Cellular proviral HIV type 1 DNA load persists after long-term RT-inhibitor therapy in HIV type 1 infected persons. AIDS Res. Hum. Retrovir. 14:1053-1058.
7. Chew, C. B., S. J. Potter, B. Wang, Y. M. Wang, C. O. Shaw, D. E. Dwyer, and N. K. Saksena. 2005. Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART. J. Clin. Virol. 33:206-216.
8. Chun, T. W., L. Carruth, D. Finzi, X. Shen, J. A. DiGiuseppe, H. Taylor, M. Hermankova, K. Chadwick, J. Margolick, T. C. Quinn, Y. H. Kuo, R. Brookmeyer, M. A. Zeiger, P. Barditch-Crovo, and R. F. Siliciano. 1997. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387:183-188.
9. Escaich, S., J. Ritter, P. Rougier, D. Lepot, J. P. Lamelin, M. Sepetjan, and C. Trepo. 1992. Relevance of the quantitative detection of HIV proviral sequences in PBMC of infected individuals. AIDS Res. Hum. Retrovir. 8:1833-1837.
10. Fiscus, S. A., D. Brambilla, L. Grosso, J. Schock, and M. Cronin. 1998. Quantitation of human immunodeficiency virus type 1 RNA in plasma by using blood dried on filter paper. J. Clin. Microbiol. 36:258-260.
11. Johnson, J. A., J.-F. Li, A. Brant, D. Bennett, M. Cong, T. Spira, P. Sandstrom, and W. Heneine. 2005. Multi-drug resistant HIV-1 are transmitted more frequently than current estimates. Antivir. Ther. 10:S124.
12. Johnson, V. A, F. Brun-Vézinet, B. Clotet, B. Conway, D. R. Kuritzkes, D. Pillay, J. M. Schapiro, A. Telenti, and D. D. Richman. 2005. Update of the drug resistance mutations in HIV-1: fall 2005. Topics HIV Med. 13:125-131.
13. Kalish, M. L., K. E. Robbins, D. Pieniazek, A. Schaefer, N. Nzilambi, T. C. Quinn, M. E. St. Louis, A. S. Youngpairoj, J. Phillips, H. W. Jaffe, and T. M. Folks. 2004. Recombinant viruses and early global HIV-1 epidemic. Emerg. Infect. Dis. 10:1227-1234.
14. Koch, N., N. Yahi, F. Ariasi, J. Fantini, and C. Tamalet. 1999. Comparison of human immunodeficiency virus type 1 (HIV-1) protease mutations in HIV-1 genomes detected in plasma and in peripheral blood mononuclear cells from patients receiving combination drug therapy. J. Clin. Microbiol. 37:1595-1597.
15. Li, C. C., K. D. Seidel, R. W. Coombs, and L. M. Frenkel. 2005. Detection and quantification of human immunodeficiency virus type 1 p24 antigen in dried whole blood and plasma on filter paper stored under various conditions. J. Clin. Microbiol. 43:3901-3905.
16. Nkengasong, J. N., C. Adje-Toure, and P. J. Weidle. 2004. HIV antiretroviral drug resistance in Africa. AIDS Rev. 6:4-12.
17. O'Shea, S., J. Mullen, K. Corbett, I. Chrystie, M. L. Newell, and J. E. Banatvala. 1999. Use of dried whole blood spots for quantification of HIV-1 RNA. AIDS 13:630.
18. Panteleeff, D. D., G. John, R. Nduati, D. Mbori-Ngacha, B. Richardson, J. Kreiss, and J. Overbaugh. 1999. Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA. J. Clin. Microbiol. 37:350-353.
19. Schmit, J. C., J. Cogniaux, P. Hermans, C. Van Vaeck, S. Sprecher, B. Van Remoortel, M. Witvrouw, J. Balzarini, J. Desmyter, E. De Clercq, and A. M. Vandamme. 1996. Multiple drug resistance to nucleoside analogs and non-nucleoside reverse transcriptase inhibitors in an efficiently replicating human immunodeficiency virus type 1 patient strain. J. Infect. Dis. 174:962-968.
20. Solomon, S. S., S. Pulimi, I. Rodriguez, S. K. Chaguturu, S. K. Satish Kumar, K. H. Mayer, and S. Solomon. 2004. Dried blood spots are an acceptable and useful HIV surveillance tool in a remote developing world setting. Int. J. STD AIDS. 15:658-661.
21. Solomon, S. S., S. Solomon, I. Rodriguez, S. T. McGarvey, A. K. Ganesh, S. P. Thyagarajan, A. P. Mahajan, and K. H. Mayer. 2002. Dried blood spots (DBS): a valuable tool for HIV surveillance in developing/tropical countries. Int. J. STD AIDS 13:25-28.
22. Venturi, G., L. Romano, T. Carli, P. Corsi, L. Pippi, P. E. Valensin, and M. Zazzi. 2002. Divergent distribution of HIV-1 drug-resistant variants on and off antiretroviral therapy. Antivir. Ther. 7:245-250.
23. Vergne, L., G. Malonga-Mouellet, I. Mistoul, R. Mavoungou, H. Mansaray, M. Peeters, and E. Delaporte. 2002. Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries. J. Acquir. Immune Defic. Syndr. 29:165-168.
24. Verhofstede, C., F. V. Wanzeele, B. Van Der Gucht, N. De Cabooter, and J. Plum. 1999. Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype. AIDS 13:2541-2546.
25. Ziemniak, C., A. George-Agwu, W. J. Moss, S. C. Ray, and D. Persaud. 2006. A sensitive genotypic assay for detection of drug resistance mutations in reverse transcriptase of HIV subtypes B and C in samples stored as dried blood spots or frozen RNA extracts. J. Virol. Methods 136:238-247.